Table 1 Disease characteristics of SLE patients
| Â | SLE (n= 30) |
|---|---|
ACR criteria, n (%) | Â |
   Malar rash | 13 (43%) |
   Discoid rash | 6 (20%) |
   Photosensitivity | 12 (40%) |
   Oral ulcers | 9 (30%) |
   Arthritis | 20 (66%) |
   Serositis | 16 (53%) |
   Renal disorder | 13 (43%) |
   Neurological disorder | 1 (3%) |
   Hematological disorder | 23 (77%) |
   Immunological disorder | 26 (87%) |
   Antinuclear antibody | 30 (100%) |
Duration of disease, months | 146 (49 to 209) |
SLEDAI | 4 (2 to 4) |
Anti-dsDNA, Farr | 20 (6 to 140) |
Complement C3, g/l | 0.89 (0.74 to 1.06) |
Complement C4, g/l | 0.12 (0.09 to 0.17) |
C-reactive protein, mg/l | 1.8 (0.5 to 4.5) |
Creatinine Clearance, ml/min | 106 (93 to 131) |
Prednisolone use, n (%) | 19 (63%) |
   Dose, mg/day | 7.5 (5 to 10) |
Hydroxychloroquine use, n (%) | 15 (50%) |
   Dose, mg/dag | 400 (400 to 400) |
Azathioprine use, n (%) | 11 (37%) |
   Dose, mg/day | 100 (50 to 150) |